Quantum-Powered Cancer Detection AI by QuZone

DIM 12 is an advanced cancer detection AI system integrating deep learning, neuro-symbolic reasoning, and quantum neural networks via the QuZone platform. It delivers over 95% accuracy across 8 cancer types, offering real-time diagnostics, explainability, and seamless integration with RadiologyGPT for automated reporting.o

Case Details

Detection

Architecture

Accuracy

Integration

Compliancewso

Let’s Work Together for Development

Call us directly, or email us!

Address Business

Harju maakond, Tallinn, Lasnamäe linnaosa, Sepapaja tn 6, 15551 | Estonia

Contact With Us

+91-11-696-53-850
[email protected]

Working Time

Mon - Sat: 10:00 am - 20:00 pm Sunday : Closed

Get in Touch With Us

Problem Statement

Early and accurate detection of cancer is hindered by fragmented data, diagnostic variability, and a shortage of radiology experts.

Delayed Diagnosis: Traditional methods often fail to detect cancer at early stages, reducing survival chances.
Overburdened Radiologists: High patient load leads to burnout and diagnostic delays.
Fragmented Data: Medical imaging, pathology, and genomics often exist in silos, leading to incomplete analysis.
Limited AI Adoption: Healthcare systems lack integrated AI tools that provide explainable and compliant results.

Solution

DIM12, powered by RadiologyGPT and QuZone, offers a unified, AI-driven diagnostic platform for early cancer detection and radiology automation.

A next-generation AI model designed for precision oncology, multi-cancer detection, and regulatory-aligned deployment.

Multi-Cancer Detection: Detects 8 major cancers using imaging and pathology data for comprehensive diagnostics.
Quantum Integration: Uses Quantum Neural Networks (QNNs) to speed up inference and improve accuracy.
FDA & UAE Compliant: Achieves >95% accuracy, aligning with international healthcare regulatory standards.
Deep Learning Backbone: 12-layer model with 1.15 billion parameters ensures robust performance across diverse datasets.

A multimodal LLM for real-time radiological analysis and automated reporting.

Automated Imaging Interpretation: Processes X-rays, MRIs, and CT scans to assist radiologists in real-time.
Multimodal Fusion: Combines text, image, and audio data to improve diagnostic decision-making.
EHR Compatible: Seamlessly integrates with hospital systems and electronic health records.
Scalable Deployment: Cloud and on-premise availability tailored for institutions of all sizes.

Technical Implementation

1. AI & Deep Learning

Convolutional Neural Networks (CNNs) for image recognition and tumor segmentation.

Radiomics to convert imaging data into quantifiable patterns

2. Quantum Neural Network

Quantum-enhanced layers reduce inference time.

Adaptive learning to improve rare cancer detection.

3. Neurosymbolic AI & EBMs

Adds logical reasoning to neural networks for explainable predictions.

Uses energy-based scoring for handling uncertainty in results.

Cancer AI Use Cases

DIM12 is uniquely trained to detect 8 major cancer types—Skin, Ovarian, Kidney, Brain, Cervical, Lung, Colon, and Prostate—offering comprehensive diagnostic coverage across oncological disciplines. Each model is fine-tuned with cancer-specific imaging and pathology data to enhance sensitivity and specificity.

Through whole-slide image analysis, DIM12 distinguishes between benign and malignant tissues with high accuracy. It performs detailed histological grading, mitotic index calculation, and nuclear morphology analysis, enabling better clinical decisions in biopsy-based diagnostics.

The system integrates radiological data with genomic profiles such as RNA-seq and WGS. This enables oncologists to uncover mutation-driven cancer patterns, improve risk stratification, and suggest personalized treatment plans based on both phenotype and genotype.

AI-driven survival modeling, treatment outcome simulation, and disease progression forecasting help clinicians plan patient-specific therapies. DIM12’s support for Cox regression and DeepSurv models ensures better long-term planning and improved patient management.

Conclusion

Quzones is revolutionizing urban transportation by leveraging quantum computing to optimize fleet dispatch, routing, and multi-modal transit systems. By integrating Quantum Neural Networks (QNNs), Variational Algorithms (QVAs), and Quantum Annealing (QA), Quzones provides a future-ready solution for smarter, greener, and more efficient cities.

As quantum computing continues to advance, its application in smart urban mobility solutions will unlock unprecedented efficiency gains, making transportation faster, more cost-effective, and environmentally sustainable.